跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,021 条关于
“XLP”
全部
2,021
临床试验
1,074
药物
422
机构
50
资讯
475
11个月前
GondolaBio's PORT-77 Receives FDA Orphan Drug and Fast Track Designations for Rare Protoporphyria Treatment
昨天
FDA Accepts Dersimelagon NDA With Priority Review as LEO Pharma Closes Tanabe Acquisition
去年
Disc Medicine Announces End-of-Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria
去年
FDA Aligns with Gemini Therapeutics on APOLLO Trial Design for Bitopertin in Rare Porphyria Disorders
去年
Disc Medicine's Bitopertin Poised for Potential Accelerated FDA Approval in Erythropoietic Protoporphyria
去年
Disc Medicine Gains FDA Alignment on Bitopertin Trial Design for Erythropoietic Protoporphyria
上个月
LEO Pharma Acquires Worldwide Rights to Dersimelagon for Up to $435 Million
去年
Disc Medicine Advances Hematology Pipeline with Bitopertin NDA Plans and Phase 2 Trials
去年
Rani Therapeutics Achieves Bioequivalence with Oral GLP-1/GLP-2 Dual Agonist for Obesity Treatment
8个月前
Rani Therapeutics Launches Phase 1 Trial of Oral GLP-1/GLP-2 Dual Agonist RT-114 for Obesity Treatment
第 1 页,共 48 页
上一页
下一页